Skip to main content
See every side of every news story
Published loading...Updated

Immuno Cure Deploys Scientist Team to Manage Research Facility for Therapeutic DNA Vaccine for HIV at Center of International Innovation for Technology and Science

Summary by Slovenia Times
Another significant step towards the success of ICVAX® HONG KONG SAR - Media OutReach Newswire - 27 May 2026 - Immuno Cure Group ("Immuno Cure"), headquartered at Hong Kong Science Park, is pleased to announce the inauguration of the research facility for its HIV therapeutic DNA vaccine ("ICVAX®") at the Center of International Innovation for Technology and Science ("CIITS") located in Hetao, Shenzhen. The facility aims for the development and …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The InfoStride broke the news on Wednesday, May 27, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal